Abstract
Head and neck cancer (HNC) encompasses a range of malignancies that originate from the upper aerodigestive tract. Despite employing a multimodal treatment approach, the recurrence rate for HNC remains high with limited treatment options. One effective treatment method for HNC is interstitial brachytherapy with radioactive seeds, which delivers high localized doses of radiation while minimizing damage to surrounding healthy tissues. The integration of three-dimensional-printed templates (3D-PT) with computed tomography (CT)-guided techniques enhances the precision and control of radioactive seed implantation. This approach enhances treatment accuracy and efficacy, making it a valuable option in the management of HNC and other malignancies. Several factors, such as the specific target site, puncture trajectory, and radiation dosage distribution, can influence the efficacy and safety of seed implantation. At present, there is a lack of comprehensive reports detailing the clinical and technical processes and standards related to 3D-PT-assisted CT-guided particle implantation therapy for recurrent HNC. This consensus aims to address this gap by focusing on the application of 3D-PTs for interstitial brachytherapy using iodine-125 seeds in the treatment of recurrent HNC.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call